Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial. (2018)

First Author: El-Damanawi R
Attributed to:  Adaptive Clinical Trials funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-022859

PubMed Identifier: 29743334

Publication URI: http://europepmc.org/abstract/MED/29743334

Type: Journal Article/Review

Volume: 8

Parent Publication: BMJ open

Issue: 5

ISSN: 2044-6055